Popular on TelAve
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- Syxsense Confirms There is Zero SolarWinds® Orion® in its Environment and is Not a SolarWinds Customer
- Grammy nominated, Multiplatinum Producer "Khao" partners with tech company to create Christmas album for families to engage amid Covid-19
- Bid Ops Partners With Marcus Evans To Announce Optimal: The AI Conference for Procurement Teams
- RiseUP TV! Why COVID is NOT slowing us down!
- Ismail Sirdah on New Innovations in Event Promotion Marketing for a Post-COVID-19
- DMS Prioritizes Health & Wellbeing Of Employees
- The Kawagoe Tobu Hotel Celebrates its 6-Month Anniversary on December 29, 2020
- Intern Pursuit Partnering With WVBR 95.3 FM
- Rio Rocket and Rosann Santos Launch The Design Your Decade Podcast, A Marriage of Career Growth And Comedy
Similar on TelAve
- AUA College of Medicine Establishes Admissions Agreement with Mississippi Valley State University
- Thomas Mitchiner Law--Unraveling the complexities of Employment Law
- Green Health Eugene and COVID Information
- Mending Kids is Holding its Eighth Hometown Mission in Long Beach, CA
- Facebook Sued by FormerFedsGroup.Com Over Pandemic Censorship and Suppression of Life Saving Health Information
- CuraLinc's New Mental Health Navigator Drives More Employees to Access Mental Health Care and Support
- Good news! The COVID-19 vaccine is coming to Whittier Health Network in Massachusetts
- OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste) in Australia for the treatment of skin cancer lesions and skin tumors
- Syxsense Offers a Year of Free IT and Patch Management Software to Vulnerable Hospitals Battling Pandemic
- Life & Loss After Stroke: Lessons from a Caregiver and Practice Perspective
SFA Therapeutics, Inc. To Present At Bio Investors Forum
TelAve News/10598950
Will Present Clinical Development Plans For Several Novel Therapeutic Agents Derived from Human Microbiome
PHILADELPHIA - TelAve -- SFA Therapeutics, Inc. announced today that their CEO, Dr. Ira Spector, will update the company's clinical development plans for several new therapeutic agents they have derived from the human microbiome. The presentation will be delivered as part of the prestigious Bio Investors Forum on October 23rd at 9:45AM in the Elizabethan Room of the Westin St. Francis Hotel in San Francisco, CA.
About SFA Therapeutics
SFA Therapeutics, Inc. is a bio-pharmaceutical company focused on new human-microbiome-based advancements in the treatment of inflammatory diseases, targeting NF-kB and RAS. Chronic inflammation has been implicated in a wide range of diseases, including HCC, Psoriatic Arthritis, Rheumatoid Arthritis, Lupus (SLE), Inflammatory Bowel Disease (IBD), Crohn's Disease, Liver Disease and relapse/recurrence in AML and CML. SFA currently has five drugs under development, and is targeting psoriasis, Hepatitis B and Hepatocellular Carcinoma (liver cancer) with their lead assets.
More on TelAve News
SFA's small-molecule drugs are derived from natural substances produced in the human microbiome and enable a new platform for developing safer treatments for inflammatory diseases. SFA's drug development platform has been exclusively licensed from Temple University to SFA Therapeutics in Jenkintown, PA. Please visit www.sfatherapeutics.com to learn more.
About SFA Therapeutics
SFA Therapeutics, Inc. is a bio-pharmaceutical company focused on new human-microbiome-based advancements in the treatment of inflammatory diseases, targeting NF-kB and RAS. Chronic inflammation has been implicated in a wide range of diseases, including HCC, Psoriatic Arthritis, Rheumatoid Arthritis, Lupus (SLE), Inflammatory Bowel Disease (IBD), Crohn's Disease, Liver Disease and relapse/recurrence in AML and CML. SFA currently has five drugs under development, and is targeting psoriasis, Hepatitis B and Hepatocellular Carcinoma (liver cancer) with their lead assets.
More on TelAve News
- Dollyhood Records Signs Distribution Deal With Sony!
- CPT Network Solutions launches CPT Voice
- West Coast Recording Artist, Composer and Actor, Blue Ragg$ Releases New Music & Theatrical Video
- Swaggerty's Receives Highest Possible Grade from BRC Food Safety Auditors for 8th Consecutive Year
- Be an Example, Get the Covid Shot
SFA's small-molecule drugs are derived from natural substances produced in the human microbiome and enable a new platform for developing safer treatments for inflammatory diseases. SFA's drug development platform has been exclusively licensed from Temple University to SFA Therapeutics in Jenkintown, PA. Please visit www.sfatherapeutics.com to learn more.
Source: SFA Therapeutics, Inc.
0 Comments
Latest on TelAve News
- Morningstar names Quantified STF Fund top-performing tactical-allocation fund in 2020
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- SHELTER, New Works by Artists Byron Keith Byrd, Stefani Byrd, and Fenix Gallery Collective, January 20–February 24, 2021
- AI.Reverie Awarded $950 Million IDIQ Contract for U.S. Air Force Advanced Battle Management System (ABMS)
- Updated ASI Book Helps Association Executives Improve Organizational Performance Now and Post-COVID
- MBK Senior Living Ranks 7th On Fortune Best Workplaces For Aging Services List
- Fifth Gen Media announces Darlene Pope as Chairman of the Advisory Council
- Phinge To Launch Netverse, a Rewards-Based Alternative to Apple and Google Using Innovative Proprietary Technology and Patented Mobile Devices
- Programmatic Advertising Emerges as a Major Margin Expansion Opportunity for Pay TV Providers in 2021
- Spivey Hall Children's Choir Looks To 2021 Through The Lens of Langston Hughes Poetry
- CNet Training Celebrates its 25th Anniversary
- Wohler releases AoIP & Analog options for their iVAM1-1
- While Supplies Last: Thermal Transfer Label Sale
- The Business Consultant behind The First Black-owned BP
- Overstock Promo: Thermal Transfer Labels On Sale Now
- Weddings Beautiful Worldwide announces Jacqueline Vazquez as new CEO
- Dr. Linda Howe releases new book, Inspired Manifesting
- Milestone: Total Technicolor Deployments of DOCSIS 3.1 Gateways Reaches 20 Million Units Worldwide
- Official CMT Artist Ashley Wineland to Release Title Track from Upcoming Album 'I'm Gonna Ride'
- Why Medical Massage Means More Guarantees of Pain Relief for Massage Patients in Los Angeles